FR2509304A1 - Allophanoylpiperazine et composition analgesique contenant ce compose comme ingredient actif - Google Patents

Allophanoylpiperazine et composition analgesique contenant ce compose comme ingredient actif Download PDF

Info

Publication number
FR2509304A1
FR2509304A1 FR8113664A FR8113664A FR2509304A1 FR 2509304 A1 FR2509304 A1 FR 2509304A1 FR 8113664 A FR8113664 A FR 8113664A FR 8113664 A FR8113664 A FR 8113664A FR 2509304 A1 FR2509304 A1 FR 2509304A1
Authority
FR
France
Prior art keywords
group
piperazine
trimethylallophanoyl
lower alkyl
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8113664A
Other languages
English (en)
French (fr)
Other versions
FR2509304B1 (enExample
Inventor
Hajime Fujimura
Yasuzo Hiramatu
Takahiro Yabuuchi
Masakatu Hisaki
Katsuo Takikawa
Takaji Honna
Hidekazu Mitake
Makoto Kajitani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of FR2509304A1 publication Critical patent/FR2509304A1/fr
Application granted granted Critical
Publication of FR2509304B1 publication Critical patent/FR2509304B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8113664A 1981-07-14 1981-07-10 Allophanoylpiperazine et composition analgesique contenant ce compose comme ingredient actif Granted FR2509304A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08121673A GB2101580B (en) 1981-07-14 1981-07-14 Allophanoylpiperazine compounds

Publications (2)

Publication Number Publication Date
FR2509304A1 true FR2509304A1 (fr) 1983-01-14
FR2509304B1 FR2509304B1 (enExample) 1984-06-08

Family

ID=10523228

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8113664A Granted FR2509304A1 (fr) 1981-07-14 1981-07-10 Allophanoylpiperazine et composition analgesique contenant ce compose comme ingredient actif

Country Status (6)

Country Link
US (1) US4666911A (enExample)
CH (1) CH648029A5 (enExample)
DE (1) DE3127789A1 (enExample)
FR (1) FR2509304A1 (enExample)
GB (1) GB2101580B (enExample)
NL (1) NL191368C (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
DE3410613A1 (de) * 1983-03-25 1984-10-11 Degussa Ag, 6000 Frankfurt Neue n-phenyl-n'-cycloalkylalkanoyl-piperazine und verfahren zu deren herstellung
US4994455A (en) * 1987-10-26 1991-02-19 Pfizer Inc. Anti-anxiety agents
US6372795B1 (en) * 2000-06-30 2002-04-16 Unilever Home And Personal Care Usa, A Division Of Conopco, Inc. Cosmetic compositions containing substituted amide derivatives
US20050124625A1 (en) * 2003-10-21 2005-06-09 Salvati Mark E. Piperazine derivatives and their use as modulators of nuclear hormone receptor function
US8927546B2 (en) * 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
SG171634A1 (en) * 2006-02-28 2011-06-29 Helicon Therapeutics Inc Therapeutic piperazines as pde4 inhibitors
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
EA023972B1 (ru) * 2008-02-21 2016-08-31 Рихтер Гедеон Нирт. Стабильный твёрдый препарат карипразина для перорального введения и способ его получения
HRP20150196T1 (hr) 2008-07-16 2015-06-05 Richter Gedeon Nyrt. Farmaceutske formulacije s ligandima receptora dopamina
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012123A1 (de) * 1979-03-31 1980-10-02 Taiho Pharmaceutical Co Ltd Pharmazeutisches mittel auf der basis von 1,1,3,5-substituierten biuretverbindungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE563390A (enExample) * 1956-12-21
NL281394A (enExample) * 1961-07-25
US3251737A (en) * 1962-11-05 1966-05-17 Horner Frank W Ltd Methods for inhibiting gastric secretions with substituted biurets
GB1096005A (en) * 1965-03-09 1967-12-20 Horner Frank W Ltd Substituted biurets
FR2081564A1 (en) * 1970-03-05 1971-12-10 Delalande Sa N-amino carbonyl-piperazines analgesics - antiinflammatories ,hypotensives and spasmolytics
US3686244A (en) * 1970-04-27 1972-08-22 Exxon Research Engineering Co Metal complexes of dithiobiurets
DE2131034A1 (de) * 1971-06-23 1973-01-11 Hoechst Ag Acylharnstoffe und verfahren zu ihrer herstellung
FR2258838A1 (en) * 1974-01-25 1975-08-22 Buzas Andre 1-(2-Methoxy-4-amino-5-chloro-benzamido)-4-piperonyl-piperazine - prepd. by reacting piperonylpiperazine with 2-methoxy-4-amino-5-chlorobenzoic acid
IT1054961B (it) * 1976-01-23 1981-11-30 Corvi Camillo Spa Derivati della piperazina adatti come agenti anti ulcera
JPS549387A (en) * 1977-06-23 1979-01-24 Takenaka Komuten Co Ltd Automatic controlling method in mansion by descriminating person comming in mansion
JPS55130952A (en) * 1979-03-31 1980-10-11 Res Inst For Prod Dev 1,1,3,5-substituted biuret compound
DE3049439A1 (de) * 1980-12-30 1982-07-29 Bayer Ag, 5090 Leverkusen N-sulfenylierte biurete, verfahren zu ihrer herstellung und ihre verwendung als fungizide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012123A1 (de) * 1979-03-31 1980-10-02 Taiho Pharmaceutical Co Ltd Pharmazeutisches mittel auf der basis von 1,1,3,5-substituierten biuretverbindungen

Also Published As

Publication number Publication date
GB2101580B (en) 1985-03-27
NL8103286A (nl) 1983-02-01
DE3127789A1 (de) 1983-01-27
US4666911A (en) 1987-05-19
CH648029A5 (de) 1985-02-28
FR2509304B1 (enExample) 1984-06-08
NL191368C (nl) 1995-06-16
NL191368B (nl) 1995-01-16
GB2101580A (en) 1983-01-19

Similar Documents

Publication Publication Date Title
US4207324A (en) 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
FR2509304A1 (fr) Allophanoylpiperazine et composition analgesique contenant ce compose comme ingredient actif
EP0516520A1 (fr) Pipéridines disubstituées-1,4, leur préparation et leur application en thérapeutique
FR2493315A1 (fr) Derive de piperazine, procede pour sa preparation et composition analgesique en contenant
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
FR2679555A1 (fr) Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
EP0239461A1 (fr) Dérivés de N-¬¬(hydroxy-2 phényl) (phényl) méthylène amino-2 éthyl acétamide, leur préparation et leur application en thérapeutique
FR2663328A1 (fr) Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2662442A1 (fr) Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
FR2601011A1 (fr) Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
CA1209995A (fr) Procede pour la preparation de composes de nicotinamide 1-oxyde n-substitue et de ses sels, et les composes et sels ainsi obtenus
BE897617A (fr) Thioesters d'acide acetylsalicylique procede pour les preparer et compositions pharmaceutiques qui en renferment
FR2559151A1 (fr) Derives de l'arginine et sels d'addition d'acides correspondants pharmaceutiquement acceptables et compositions pharmaceutiques les contenant
EP0173585B1 (fr) Médicaments à base de dérivés de la pipéridine, nouveaux dérivés de la pipéridine et leurs procédés de préparation
FR2636064A1 (fr) Thioformamidines, leur preparation et leur application en tant que medicaments
FR2600647A1 (fr) Derives de la glycine
SU1547708A3 (ru) Способ получени третбутил производного эрголина
US5169859A (en) Thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same
HU198915B (en) Process for producing new 2-thiazolidinone derivatives and pharmaceutical compositions containing them
FR2649981A1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
KR850001038B1 (ko) 알로파노일 피페라진 화합물의 제조방법
EP0101379A1 (fr) Benzamides, leurs sels, procédé pour leur préparation et compositions pharmaceutiques les renfermant
EP0382636A1 (fr) Dérivés de pyrimidine, 2-[4-(alpha-heteroaryl-alpha aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl], avec activité serotoninergique

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse
ST Notification of lapse